Montag & Associates’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Hold
1,499
– – ﹤0.01% 490
2026
Q1
$97.9K Hold
1,499
– – ﹤0.01% 507
2025
Q4
$119K Hold
1,499
– – 0.01% 483
2025
Q3
$109K Sell
1,499
-105
-7% -$7.7K 0.01% 476
2025
Q2
$122K Sell
1,604
-104
-6% -$7.36K 0.01% 455
2025
Q1
$130K Sell
1,708
-25
-1% -$1.86K 0.01% 464
2024
Q4
$114K Sell
1,733
-19
-1% -$1.33K 0.01% 482
2024
Q3
$122K Sell
1,752
-53
-3% -$3.19K 0.01% 482
2024
Q2
$95.4K Buy
+1,805
New +$110K ﹤0.01% 495

Other funds holding SOLV

Montag & Associates's SOLV Position: Q2 2026 in Review

Montag & Associates held its Solventum (SOLV) position steady in Q2 2026 at 1,499 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Montag & Associates first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $130K in Q1 2025. 885 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Montag & Associates held 1,499 shares of Solventum worth $116K as of Q2 2026.
  • Montag & Associates left its Solventum share count unchanged in Q2 2026.
  • Solventum made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #490 holding.
  • Montag & Associates first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Montag & Associates's Solventum position peaked at $130K in Q1 2025.
  • 885 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.